RA CAPITAL MANAGEMENT, L.P. sold PRLD
April 27, 2026 · Form 4 insider transaction
RA CAPITAL MANAGEMENT, L.P. sold 1,407,000 shares of Prelude Therapeutics Incorporated, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
On April 27, 2026, RA Capital Healthcare Fund, L.P. (the "Fund") entered into an Exchange Agreement with the Issuer pursuant to which the Fund exchanged, for no additional consideration, 1,407,000 shares of the Issuer's Common Stock for a pre-funded warrant exercisable for up to 1,407,000 shares of the Issuer's Common Stock at an exercise price of $0.0001 per share (the "Pre-Funded Warrant").; Held directly by the Fund.; RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.